References
- Nobile-Orazio E. Neuropathy and monoclonal gammopathy. Hematologica 2004; 89: 23–29
- Noblie-Orazio E. IgM paraproteinaemic neuropathies. Curr Opin Neurol 2004; 17: 599–605
- Dimopoulos M A, Kyle R A, Anagnostopoulos A, Treon S P. Diagnosis and management of Waldenstrom's macroglobulinemia. J Clin Oncol 2005; 23: 1564–1577
- Johnson S A, Owen R G, Oscier D G, Leblond V, Levy V, Jaeger U, Seymour J F. Phase III study of Chlorambucil versus Fludarabine initial therapy for Waldenstrom's macroglobulinemia and related disorders. Clin Lymphoma 2005; 5: 294–297
- Maloney D G. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines. J Clin Oncol 2005; 23: 6421–6428
- Dispenzieri A, Kyle R A. Neurological aspects of multiple myeloma and related disorders. Best Pract Res Clin Haematol 2005; 18: 673–688
- Owen R G. Monoclonal immunoglobulins and peripheral neuropathy: causative agent or coincidental finding?. Clin Lymphoma 2004; 5: 172–173
- Bjorkholm M. Treatment options in Waldenstrom's macroglobulinemia. Clin Lymphoma 2004; 5: 155–162
- Weber D M, Dimopoulos M A, Delasalle K, Rankin K, Gavino M, Alexanian R. 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's Macroglobulinemia. Semin Oncol 2003; 30: 243–247
- Dimopoulos M A, Alexanian R, Gika D, Anagnostopoulos A, Zervas C, Zomas A, et al. Treatment of Waldenstrom's macroglobulinemia with Rituximab: prognostic factors for response. Leuk Lymphoma 2004; 45: 2057–2061
- Pestronk A, Florence J, Miller T, Choksi R, Al-Lozi M T, Levine T D. Treatment of IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg Psychiatry 2003; 74: 485–489